These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 28859138)
21. The potential of volatile organic compounds for the detection of active disease in patients with ulcerative colitis. Smolinska A; Bodelier AG; Dallinga JW; Masclee AA; Jonkers DM; van Schooten FJ; Pierik MJ Aliment Pharmacol Ther; 2017 May; 45(9):1244-1254. PubMed ID: 28239876 [TBL] [Abstract][Full Text] [Related]
22. Inflammatory bowel diseases: controversies in the use of diagnostic procedures. Vucelic B Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751 [TBL] [Abstract][Full Text] [Related]
23. Pancreatic ductal adenocarcinoma can be detected by analysis of volatile organic compounds (VOCs) in alveolar air. Princivalle A; Monasta L; Butturini G; Bassi C; Perbellini L BMC Cancer; 2018 May; 18(1):529. PubMed ID: 29728093 [TBL] [Abstract][Full Text] [Related]
24. Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. Papa E; Docktor M; Smillie C; Weber S; Preheim SP; Gevers D; Giannoukos G; Ciulla D; Tabbaa D; Ingram J; Schauer DB; Ward DV; Korzenik JR; Xavier RJ; Bousvaros A; Alm EJ PLoS One; 2012; 7(6):e39242. PubMed ID: 22768065 [TBL] [Abstract][Full Text] [Related]
25. Value of fractional exhaled nitric oxide (FE NO) for the diagnosis of pulmonary involvement due to inflammatory bowel disease. Ozyilmaz E; Yildirim B; Erbas G; Akten S; Oguzulgen IK; Tunc B; Tuncer C; Turktas H Inflamm Bowel Dis; 2010 Apr; 16(4):670-6. PubMed ID: 19705414 [TBL] [Abstract][Full Text] [Related]
26. Simultaneous Assessment of Urinary and Fecal Volatile Organic Compound Analysis in De Novo Pediatric IBD. El Manouni El Hassani S; Bosch S; Lemmen JPM; Brizzio Brentar M; Ayada I; Wicaksono AN; Covington JA; Benninga MA; de Boer NKH; de Meij TGJ Sensors (Basel); 2019 Oct; 19(20):. PubMed ID: 31623289 [TBL] [Abstract][Full Text] [Related]
27. Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Ahmed I; Greenwood R; Costello B; Ratcliffe N; Probert CS Aliment Pharmacol Ther; 2016 Mar; 43(5):596-611. PubMed ID: 26806034 [TBL] [Abstract][Full Text] [Related]
28. Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children. Filimoniuk A; Blachnio-Zabielska A; Imierska M; Lebensztejn DM; Daniluk U Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708181 [TBL] [Abstract][Full Text] [Related]
29. On the importance of accurate quantification of individual volatile metabolites in exhaled breath. Smith D; Španěl P J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619 [TBL] [Abstract][Full Text] [Related]
31. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma. Kumar S; Huang J; Abbassi-Ghadi N; Mackenzie HA; Veselkov KA; Hoare JM; Lovat LB; Španěl P; Smith D; Hanna GB Ann Surg; 2015 Dec; 262(6):981-90. PubMed ID: 25575255 [TBL] [Abstract][Full Text] [Related]
32. Inflammatory cytokines in exhaled breath condensate in children with inflammatory bowel diseases. Krenke K; Peradzyńska J; Lange J; Banaszkiewicz A; Łazowska-Przeorek I; Grzela K; Radzikowski A; Kulus M Pediatr Pulmonol; 2014 Dec; 49(12):1190-5. PubMed ID: 24339443 [TBL] [Abstract][Full Text] [Related]
33. Analysis of breath volatile organic compounds in children with chronic liver disease compared to healthy controls. Eng K; Alkhouri N; Cikach F; Patel N; Yan C; Grove D; Lopez R; Rome E; Dweik RA J Breath Res; 2015 Apr; 9(2):026002. PubMed ID: 25891513 [TBL] [Abstract][Full Text] [Related]
34. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic yield of upper endoscopy in paediatric patients with Crohn's disease and ulcerative colitis. Subanalysis of the HUPIR registry. Kovacs M; Muller KE; Arato A; Lakatos PL; Kovacs JB; Varkonyi A; Solyom E; Polgar M; Nemes E; Guthy I; Tokodi I; Toth G; Horvath A; Tarnok A; Tomsits E; Csoszánszky N; Balogh M; Vass N; Bodi P; Dezsofi A; Gardos L; Micskey E; Papp M; Szucs D; Cseh A; Molnar K; Szabo D; Veres G; J Crohns Colitis; 2012 Feb; 6(1):86-94. PubMed ID: 22261532 [TBL] [Abstract][Full Text] [Related]
37. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007 [TBL] [Abstract][Full Text] [Related]
38. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease. Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807 [TBL] [Abstract][Full Text] [Related]
39. Clinical application of the multigene analysis test in discriminating between ulcerative colitis and Crohn's disease: a retrospective study. Janczewska I; Kapraali M; Saboonchi F; Nekzada Q; Wessulv Å; Khoshkar J; Marouf F; Gorsetman J; Risberg D; Lissing M; Wirström G; Sandstedt B Scand J Gastroenterol; 2012 Feb; 47(2):162-9. PubMed ID: 22229803 [TBL] [Abstract][Full Text] [Related]
40. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Jiang L; Xia B; Li J; Ye M; Yan W; Deng C; Ding Y; Luo H; Hou W; Zhao Q; Liu N; Ren H; Hou X; Xu H Inflamm Bowel Dis; 2006 Mar; 12(3):212-7. PubMed ID: 16534423 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]